Isthmus Partners LLC Has $1.98 Million Stake in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Isthmus Partners LLC raised its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 28,291 shares of the semiconductor company’s stock after purchasing an additional 507 shares during the quarter. Isthmus Partners LLC owned 0.09% of Axcelis Technologies worth $1,977,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of ACLS. US Bancorp DE raised its position in Axcelis Technologies by 13.5% during the third quarter. US Bancorp DE now owns 4,131 shares of the semiconductor company’s stock valued at $433,000 after buying an additional 490 shares during the period. Van ECK Associates Corp grew its stake in Axcelis Technologies by 40.0% during the 3rd quarter. Van ECK Associates Corp now owns 23,751 shares of the semiconductor company’s stock valued at $2,490,000 after acquiring an additional 6,786 shares in the last quarter. Crossmark Global Holdings Inc. increased its holdings in shares of Axcelis Technologies by 5.8% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 2,398 shares of the semiconductor company’s stock valued at $251,000 after purchasing an additional 132 shares during the period. State of New Jersey Common Pension Fund D lifted its position in shares of Axcelis Technologies by 6.1% in the third quarter. State of New Jersey Common Pension Fund D now owns 18,065 shares of the semiconductor company’s stock worth $1,894,000 after purchasing an additional 1,031 shares in the last quarter. Finally, Versor Investments LP boosted its holdings in shares of Axcelis Technologies by 286.7% during the third quarter. Versor Investments LP now owns 7,831 shares of the semiconductor company’s stock worth $821,000 after purchasing an additional 5,806 shares during the period. Hedge funds and other institutional investors own 89.98% of the company’s stock.

Analyst Upgrades and Downgrades

ACLS has been the subject of a number of research analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Axcelis Technologies in a research report on Wednesday, February 12th. William Blair cut Axcelis Technologies from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Finally, Craig Hallum dropped their target price on Axcelis Technologies from $115.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, January 15th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $154.00.

Axcelis Technologies Trading Up 3.0 %

Shares of NASDAQ:ACLS opened at $60.63 on Monday. Axcelis Technologies, Inc. has a 1 year low of $53.67 and a 1 year high of $158.61. The firm has a fifty day moving average price of $66.15 and a 200 day moving average price of $81.24. The company has a current ratio of 5.41, a quick ratio of 4.05 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.95 billion, a PE ratio of 9.86, a P/E/G ratio of 4.52 and a beta of 1.62.

Axcelis Technologies (NASDAQ:ACLS) last issued its quarterly earnings data on Monday, February 10th. The semiconductor company reported $1.54 EPS for the quarter, beating analysts’ consensus estimates of $1.25 by $0.29. Axcelis Technologies had a return on equity of 21.02% and a net margin of 19.75%. Analysts expect that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.